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Type 2 diabetes (T2D) is a major metabolic disease and a key epigenetic risk factor for the development of additional clinical
complications. Among them, periodontitis (PD), a severe inflammatory disease ascribable to a dysregulated physiology and
composition of the oral microbiota, represents one of the most relevant complications. Periodontitis can impact the structure of
the tooth and likely the stem and progenitor cell pool, which actively contributes to the periodontal microenvironment and
homeostasis. Modifications of the oral plaque play a key role in the etiopathogenesis of PD caused by T2D. However, to what
extent the biology of the progenitor pool is affected has still to be elucidated. In this short report, we aimed to explore the
biological effects of oral plaque derived from T2D patients with PD in comparison to non-diabetic patients with PD. Oral
plaque samples were isolated from T2D and non-diabetic subjects with PD. Dental pulp stem cells (DPSCs), derived from the
premolar tooth, were conditioned for 21 days with oral plaque samples and tested for their clonogenic ability. Cultures were also
induced to differentiate towards the osteogenic lineage, and ALP and osteocalcin gene expression levels were evaluated by
real-time qPCR. Results have shown that the number of clones generated by DPSCs exposed to T2D oral plaque was significantly
lower compared to controls (ctl). The multivariate analysis confirmed that the decreased clonogenesis was significantly correlated
only with T2D diagnosis. Moreover, the effect of T2D oral plaque was specific to DPSCs. Indicators of osteogenic differentiation
were not significantly affected. This study provides a new biological insight into the effects ascribable to T2D in PD.
1. Introduction
Type 2 diabetes (T2D) is a very common metabolic disease
caused by resistance to insulin and consequent systemic
hyperglycaemia. The pathological effects induced by T2D
are chronic and exhibit multifaceted features, as they imply
profound alterations in both the endocrine asset and meta-
bolic/physiological functions of several biological systems
[1–3], including the oral microenvironment [4, 5]. In this
regard, periodontitis (PD), a severe inflammatory disorder
of the periodontium caused by oral bacterial challenge, is a
complication of T2D [6]. In fact, patients affected by T2D
are more susceptible to PD. The periodontium is a highly
vascularised system, and oral plaque possesses intrinsic bio-
logical properties such as the pivotal chemotactic ability for
immune cells [7]. Type 2 diabetes severely impairs the archi-
tecture of periodontal tissue and interferes with basic cellular
functions such as phagocytosis, migration, and more impor-
tantly the innate immune response provided by the epithelial
mucosa of the periodontium. Importantly, the unbalanced
inflammatory and dysmetabolic state in T2D significantly
affects the composition of the bacterial film in the oral pla-
que, therefore impairing periodontal integrity and function
[8]. This scenario is further exacerbated by modifications
both in macro and microcirculation of the periodontium,
ascribable to T2D due to the increase in glycation
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end-products (AGEs), oxidative stress and deregulation of
the endothelial barrier [8]. Intriguingly, PD and diabetes
mutually influence each other in a bidirectional fashion: dia-
betes increases proinflammatory levels of soluble mediators,
therefore reinforcing periodontal inflammation; in turn, PD
influences the glycaemic index in diabetic patients [9].
Moreover, epidemiological studies have demonstrated that
PD is strictly associated with increased cardiovascular risk
as a direct consequence of endothelial dysfunction following
changes of oral plaque [10]. Notably, T2D-induced oral pla-
que modifications are not limited to the sole periodontium,
but they could likely affect defined cell populations of dental
origin and mainly progenitors of mesenchymal origin,
which reside in the tooth canal opening in the periodon-
tium. Dental pulp stem cells (DPSCs) have been defined as
adult progenitor cells of ectodermal origin, exhibiting
mesenchymal features [11–13], including clonogenic and
self-renewal capacity, mesodermal-like differentiation, and
mainly osteogenic, mineralization, and regeneration
capabilities [14, 15]. Interestingly, transplanted DPSCs in
streptozotocin-induced diabetic mouse models have
confirmed the ability of DPSCs both to enhance glucose
tolerance in a paracrine manner [16, 17] and to restore
vascular function [18, 19]. Dental pulp stem cells have
been also reported as effective candidates to generate
insulin-producing cells [20–22], parallel to a peculiar and
attractive feature of anti-inflammatory and nociceptive solu-
ble mediator-based secretion [21]. Importantly, the progres-
sion of PD in the presence of T2D is certainly dependent
on the plaque-host relationship, which may vary between
individuals. To date, biological and molecular mechanisms
underlying the interplay between DPSC properties and
alterations of the oral microenvironment caused by T2D
are still to be addressed. Here, we investigate the effects of
T2D-related oral dysbiosis and its potential biological conse-
quences that might involve DPSCs, responsible for the dental
stemness homeostasis and regenerative properties. Accord-
ingly, we hypothesize a direct biological effect of T2D oral
plaque on DPSC function and differentiation beyond the sole
involvement of the periodontium. We found that oral plaque
obtained from T2D patients with PD significantly reduced
the clonogenic ability of DPSCs compared to that obtained
from nondiabetic patients with PD, without impacting oste-
ogenic differentiation, analysed by the expression of both
alkaline phosphatase (ALP) and osteocalcin, known to repre-
sent specific markers of the osteoblast lineage [23] and to be
involved in the mineralization of the extracellular matrix and
therefore in osteogenesis [24]. Notably, the decrease in clono-
genic potential of DPSCs was independent of the main spe-
cific clinical features of diabetic patients, such as age and sex.
2. Materials and Methods
2.1. Isolation, Culture, and Characterization of Dental Pulp
Stem Cells (DPSCs) by Flow Cytometry.Dental pulp stem cells
(DPSCs) were obtained from explants of dental pulp from
one subject undergoing tooth extraction for orthodontic
treatment and according to previous reports [15, 25]. Briefly,
the premolar tooth was kept in a physiological solution after
extraction and then in milk. Afterwards, the pulp was col-
lected, chopped in a petri dish containing PBS and 1% peni-
cillin/streptomycin, and left to adhere for 2 hours at 37°C in
5% CO2 in the incubator. Afterwards, PBS was removed
and replaced by complete media composed of DMEM-low
glucose supplemented with 20% FBS and 1% penicillin/strep-
tomycin (all Gibco). After 72 hours, nonadherent cells were
removed and fresh complete media were added. DPSCs were
expanded up to the third passage by trypsinization and sub-
cultured at 4000 cells/cm2 in complete media. Cell growth
and viability were monitored by trypan blue exclusion assay.
Cultures were characterized by flow cytometry analysis. At
passage 3, DPSCs were trypsinized and resuspended in FACS
buffer (PBS/2% foetal bovine serum) for immunophenotype
assessment. Cells were stained with indirectly or directly con-
jugated primary antibodies against CD44, CD105, CD117,
CD90 (all Abcam, Cat. N. ab44967, ab6124, ab23894, and
ab5506), CD34 (Miltenyi Biotec, Calderara di Reno, Bologna,
Italy, Cat. N. 130-081-001), and CD73 (BioLegend, San
Diego, CA, USA, Cat. 344005). Cells were incubated with pri-
mary antibodies for 30 minutes, followed by staining with
secondary antibodies (only if indirectly conjugated) [11–13,
26]. Data was acquired by cytofluorimeter (FACSAria II,
BD, San Jose, CA, USA) and analysed by Diva Software
(v6.1.1, BD, San Jose, CA, USA). This study was approved
by the Ethical Committee of Policlinico Umberto I, Rome,
Italy (protocol number 4336, 02/02/2017). Experiments were
conducted in accordance with the 1964 Helsinki Declaration
regarding the study involving human participants. Informed
consent was obtained from all subjects before the surgical
procedure. Subjects were all deidentified by employing a code
(from B-F (T2D) and from G-I (ctl)). The clinical features of
all patients are reported in Table 1. Subcutaneous adipose
stromal cells (ASCs, primary cell lines 55P and 56P) were iso-
lated as previously described [11, 27], according to the
approved protocol (Ethical Committee of “Sant’Andrea”
Hospital in Rome, Ref. 49_2013/28.01.2016).
2.2. Oral Plaque Isolation. Oral plaque was isolated as previ-
ously reported [7]. Briefly, single plaque samples were firstly
spun at 400g for 5 minutes at 4°C in order to concentrate the
Table 1: Clinical features of patients.
Age Sex Smoker
Donor DPSCs
1 16 M No
Donor oral plaque
T2D-B 52 M No
T2D-C 91 F No
T2D-D 79 M No
T2D-E 94 F No
T2D-F 94 M No
Ctl-G 22 M No
Ctl-H 53 M No
Ctl-I 82 F No
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plaque. Afterwards, the pellet was weighed for the following
data normalization and mechanically homogenised using a
pestle in ice. The plaque was then diluted in 1ml of sterile
PBS and centrifuged at 4°C and 600g for 15 minutes. The
supernatant was then collected and filtered by using a
0.45μm mesh. Oral plaque suspensions were freshly used.
2.3. Clonogenic and Osteogenic Differentiation Assay. Cul-
tures were conditioned with oral plaque from diabetic and
ctl patients, by seeding DPSCs at a low density (10 cells/cm2)
in complete media, as previously described [11–13, 26], then
supplemented with an equal amount of oral plaque-derived
suspensions (volume ratio 1 : 1) for 21 days. Fresh oral plaque
suspensions were replaced every 3 days. At the end of the
incubation time, cells were fixed with 4% paraformaldehyde
for 1 hour at room temperature and then stained with
Giemsa (Sigma) in order to identify nuclear and/or cyto-
plasmic morphology of colony-forming units (CFU). The
number of clones was quantified by an optical microscope
and then normalized to the amount (mg) of the oral pla-
que seeded [11–13, 26]. For osteogenic differentiation tests,
DPSCs were cultured for 21 days in a StemPro® Osteogen-
esis Differentiation Kit (5 × 103 cells/cm2, Gibco, Cat. N.
A10072-01) [12, 13] supplemented with an equal amount
of oral plaque-derived suspensions (volume ratio 1 : 1).
Afterwards, calcium deposition was analysed incubating
the cells for 1 hour at room temperature with a 2% Aliz-
arin red solution at pH4.1-4.3 (Sigma, St. Louis, USA, Cat.
N. A5533) [13, 26].
2.4. Real-Time PCR. Total RNA was isolated (RNeasy kit,
Qiagen), and c-DNA was obtained and amplified by the
SensiMix SYBR Hi-ROX Kit (Bioline, London, UK). Tem-
plates were amplified by the 7900HT Fast Real-Time PCR
System (Applied Biosystems, Cheshire, UK) for 40 cycles
according to the following protocol: 95°C for 15 seconds,
56-58°C for 15 seconds, and 72°C for 15 seconds. Primer
sequences used were the following: forward—GATGTG
GAGTATGAGAGTGAC and reverse—GGTCAAGGGTC
AGGAGTTC (ALP), forward—TGAAAGCCGATGTGGT
CAG and reverse—CAGCGAGGTAGTGAAGAGAC
(osteocalcin), and forward—ACAGTCAGCCGCATCTTC
and reverse—GCCCAATACGACCAAATCC (GAPDH).
GAPDH was considered a housekeeping gene. The reac-
tion products were analysed by SDS 2.1.1 software
(Applied Biosystems, Cheshire, UK).
2.5. Statistical Analysis. Statistical analysis was performed by
using GraphPad Prism 5 software (San Diego, USA). Com-
parison between two groups was performed by t-test. Multi-
variable linear regression analyses were conducted to adjust
for potential confounders, and computation was performed
with SPSS 20 (IBM). A p value < 0.05 has been considered sta-
tistically significant. Data are presented as mean ± standard
error, unless specified.
3. Results
In order to test the influence of T2D patient-derived oral pla-
que on DPSC biology in the presence of PD, we have firstly
isolated and characterized the primary cell line of DPSCs
from the premolar tooth. Flow cytometry analysis showed
that DPSCs exhibited a mesenchymal stem cell-like immuno-
phenotype [11–13, 26] with high expression of stromal
markers such as CD44, CD90 and CD73 and a moderate
and low positivity for CD105 and CD117, respectively
(Figure 1(a)). The expression of CD34 (hematopoietic
marker) was undetectable. The DPSC cultures were
expanded up to the third passage, when they exhibited the
highest number of doubling viable cells (Figure 1(b), p <
0 0001 and p < 0 01, passage 3 vs. passages 1 and 2, respec-
tively). In order to evaluate their clonogenic ability, cells were
then cultured at a low density for 21 days by supplementing
the culture media with oral plaque preparations obtained
from T2D patients (N = 5) with PD. Cultures supplemented
with oral plaque from non-diabetic individuals with PD were
used as ctl (N = 3). The clinical features of subjects enrolled
in this study are displayed in Table 1. Smoking, surgical inter-
ventions, and infections have been considered exclusion cri-
teria. Results showed a striking and significant decrease in
the number of clones generated by DPSCs when conditioned
with oral plaque derived from T2D patients with PD com-
pared to ctl (Figure 1(c), p < 0 0001). Since the average age
of donors in the two groups appeared to differ, we performed
a multivariable linear regression analysis to adjust for this
potential confounder. The multivariable regression analysis
indicated a significant association between the presence of
T2D and decreased clonogenesis independently of the age
of the patient (Table 2). Afterwards, we induced DPSC differ-
entiation into the mesodermal lineage, by priming the cul-
tures for 21 days towards the osteogenic phenotype in the
presence of both types of oral plaque, and we quantified the
expression of the main osteogenic genes including ALP and
osteocalcin [28]. Results showed that T2D oral plaque did
not significantly affect the osteogenic differentiation,
although a trend of ALP to increase in cultures supplemented
with oral plaque samples derived from T2D patients with
respect to ctl was observed (Figure 1(d)).
Finally, in order to verify whether the effect of T2D oral
plaque was specific to DPSCs, we tested the samples on two
distinct human primary subcutaneous ASC lines (55P and
56P). Results have shown that the number of CFU was not
significantly affected by T2D oral plaque (Figure 2), therefore
suggesting a specific effect mainly related to the dental
microenvironment.
4. Discussion
In this study, we have shown that oral plaque derived from
T2D patients with PD impacts negatively on the clonogenic
ability of DPSCs, highlighting a potential biological mecha-
nism by which diabetes may contribute to periodontal dam-
age. To the best of our knowledge, the direct effect of
T2D-derived plaque on DPSCs has never been addressed.
Our set of diabetic patients has developed PD, whose etio-
pathogenesis is linked to a wide range of alterations triggered
in the mouth. These include changes of the periodontal
microbiota with respect to healthy individuals [28], associ-
ated in particular with the increase in defined pathogens
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[29–31], known to antagonize the immune response in
patients with PD [32]. Althoughwe did not identify the nature
of the biofilm in our oral plaque samples, it is plausible that the
microbiological profile has been profoundly modified in dia-
betic patients [8, 33, 34]. Notably, the number of CFU gener-
ated byDPSCswas negatively affected by oral plaque from this
set of T2D patients, despite the absence of significant statisti-
cal correlations with clinical parameters and potential inter-
patient variability, known to play a role in the progression of
PD even in relation to the oral microenvironment [28].
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Figure 1: (a) Flow cytometry analysis of DPSCs after isolation. The graph shows that DPSC cultures exhibit a mesenchymal-like
immunophenotype with positivity to the main stromal markers and negativity to the hematopoietic marker CD34. Representative
cytofluorimetric histograms are displayed on the right (red and green histograms and APC and FITC fluorochromes, respectively). (b)
Cell growth profile of DPSCs. The graph displays that the number of doubling cells is significantly increased at higher passages. Results
were normalized to passage 1. ∗∗p < 0 01, #p < 0 0001. (c) The graph shows that the number of clones generated by DPSCs in the
presence of T2D oral plaque is significantly lower compared to that in controls (ctls). The number of CFU was normalized to the
amount of oral plaque (mg). Below the graph, representative optical images of CFU stained with Giemsa are shown. #p < 0 0001. (d)
Osteogenic differentiation of DPSCs. The graph displays the gene expression levels of ALP and osteocalcin which are unaltered between
the two treatments. Below the graph, representative optical images of osteogenic differentiation of DPSCs stained with Alizarin red.
Magnification: 10x.
Table 2: Multivariable linear regression analysis for the
association of the normalized CFU yield (CFU/mg) and diabetes,
adjusted for age.
Independent variable Regression coefficient p
T2D -1.74 0.01
Age -0.006 0.54
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Intriguingly, when subcutaneous ASCs (stromal cells of dif-
ferent tissue origin from DPSCs) are similarly treated with
T2D oral plaque, the effect is not reproducible in our condi-
tions, indicating that the ability of T2D to decrease the clono-
genic efficiency is specific toDPSCs and likely restricted to the
dental microenvironment.
The low number of subjects enrolled in this study cer-
tainly represents a limitation. Nevertheless, we cannot rule
out that the alterations of the oral plaque mediated by diabe-
tes with regard to the intrinsic properties of DPSCs represent
a priming and sufficient event able to transversely affect indi-
viduals at any age and gender, therefore highlighting
non-cumulative effects over the time. Additionally, we have
detected a trend towards increased osteogenic differentiation
in the presence of T2D oral plaque (although not statistically
significant). This result is only apparently discrepant from
the majority of the studies in literature, showing that diabetes
severely compromises osteogenic differentiation [28, 35, 36].
However, our result should be interpreted in the light of the
clonogenesis result. In fact, normally, the biological events
related to the clonogenic and differentiation properties are
mutually exclusive and strictly dependent on the tissue of ori-
gin [11, 23]. In the majority of adult progenitor populations,
including DPSCs, the balance between these two processes is
finely tuned, and pathological insults as T2D are able to
deregulate both phases. Thus, the modifications of the oral
plaque caused by diabetes are likely to shift the ability of
DPSCs to select the proliferative clones towards a main
tendency to differentiate, therefore exhausting the original
multipotent and stromal stem cell pool. From a clinical
point of view, this effect would result in a deregulated
ossification and in the inability of patients to exploit their
own stem cell pool to trigger regeneration upon patholog-
ical conditions. Accordingly, DPSCs represent the respon-
sible population for periodontal homeostasis, able to
actively respond to different damages, by enhancing the
repairing process [15]. Notably, periodontal therapy (espe-
cially the intensive kind) in diabetic patients in combina-
tion with glycaemia control is able to successfully restore
a suitable periodontal microenvironment [33, 37, 38],
therefore confirming the reversible epigenetic nature of
T2D. Thus, it is also plausible that hyperglycaemia
consequent to insulin resistance (the hallmark of T2D
patients) may represent the key stimulus to change both
the composition of the oral plaque and the biological
features of DPSCs.
5. Conclusions
Our study strengthens the involvement of DPSCs in
T2D-mediated PD. The finding that oral plaque may repre-
sent the direct biological modality by which diabetes impairs
the dental pulp stem and progenitor cell pool could be of
clinical significance.
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